peginesatide
Sponsors
Affymax, Takeda, Amgen
Conditions
AnemiaCancerChemotherapy Induced AnemiaChronic Kidney DiseaseChronic Renal FailurePure Red Cell Aplasia
Phase 1
Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
CompletedNCT00097747
Start: 2004-08-31End: 2005-01-31Updated: 2012-12-21
A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.
TerminatedNCT00629876
Start: 2008-01-31End: 2008-06-30Updated: 2011-12-01
Phase 2
Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
TerminatedNCT00109291
Start: 2005-03-31End: 2006-02-28Updated: 2012-12-21
Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients
CompletedNCT00228436
Start: 2005-09-30End: 2007-11-30Updated: 2012-12-21
Peginesatide for Anemia in Chronic Hemodialysis Patients
CompletedNCT00228449
Start: 2005-07-31End: 2007-05-31Updated: 2012-12-21
Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy
CompletedNCT00272662
Start: 2006-01-31End: 2007-06-30Updated: 2012-12-21
Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease
CompletedNCT00314795
Start: 2006-04-06End: 2016-10-31Updated: 2019-03-14
Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD
TerminatedNCT00372489
Start: 2006-09-30End: 2009-11-30Updated: 2012-06-29
Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis
CompletedNCT00434330
Start: 2006-12-31End: 2008-04-30Updated: 2012-06-29
Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)
TerminatedNCT00453973
Start: 2006-11-30End: 2009-09-30Updated: 2012-06-29
Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA
CompletedNCT00680043
Start: 2008-06-30End: 2009-08-31Updated: 2012-06-29
Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.
CompletedNCT00752609
Start: 2008-09-30End: 2009-12-31Updated: 2012-07-27
Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.
CompletedNCT00752791
Start: 2008-10-31End: 2010-05-31Updated: 2012-08-15
Phase 3
Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
CompletedNCT00597753
Start: 2007-09-30End: 2010-01-31Updated: 2013-02-12
Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
CompletedNCT00597584
Start: 2007-10-31End: 2010-01-31Updated: 2013-03-08
Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
CompletedNCT00598442
Start: 2007-11-30End: 2009-12-31Updated: 2013-02-12
Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
CompletedNCT00598273
Start: 2007-10-31End: 2010-02-28Updated: 2013-02-12
Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
CompletedNCT01478971
Start: 2011-10-31End: 2013-02-28Updated: 2016-09-20